7,633 Shares in Marsh & McLennan Companies, Inc. $MRSH Acquired by Bryn Mawr Trust Advisors LLC

Key Points

• Bryn Mawr Trust Advisors acquired 7,633 shares of Marsh & McLennan Companies worth approximately $1.27 million. Institutional investors collectively own 87.99% of the company.
• Insiders sold 36,469 shares valued at about $6.29 million during the last quarter, while insider ownership stands at just 0.38%.
• Analysts maintain a consensus “Hold” rating with an average price target of $201.94. The company exceeded quarterly earnings expectations and raised its quarterly dividend to $0.99 per share, implying a 2.1% annual yield.

Bryn Mawr Trust Advisors LLC purchased a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 7,633 shares of the financial services provider's stock, valued at approximately $1,272,000.

Several other large investors also recently modified their holdings of MRSH. Solstein Capital LLC acquired a new position in Marsh & McLennan Companies during the 4th quarter worth approximately $25,000. Asset Dedication LLC bought a new stake in shares of Marsh & McLennan Companies during the first quarter valued at approximately $25,000. SHP Wealth Management acquired a new position in shares of Marsh & McLennan Companies during the fourth quarter worth approximately $26,000. KERR FINANCIAL PLANNING Corp bought a new position in shares of Marsh & McLennan Companies in the 4th quarter worth $27,000. Finally, Golden State Wealth Management LLC acquired a new stake in Marsh & McLennan Companies in the 4th quarter valued at $27,000. Institutional investors and hedge funds own 87.99% of the company's stock.

Insider Activity at Marsh & McLennan Companies

In related news, insider Martin South sold 7,100 shares of the company's stock in a transaction that occurred on Tuesday, July 28th. The stock was sold at an average price of $189.99, for a total value of $1,348,929.00. Following the transaction, the insider owned 16,632 shares in the company, valued at approximately $3,159,913.68. This represents a 29.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO John Q. Doyle sold 16,656 shares of the firm's stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the sale, the chief executive officer directly owned 116,811 shares of the company's stock, valued at $18,889,506.81. This represents a 12.48% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 36,469 shares of company stock valued at $6,291,345 over the last quarter. 0.38% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Citigroup downgraded shares of Marsh & McLennan Companies from a "buy" rating to a "neutral" rating and set a $200.00 price objective on the stock. in a report on Wednesday, July 22nd. Mizuho boosted their target price on shares of Marsh & McLennan Companies from $197.00 to $201.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 22nd. JPMorgan Chase & Co. upped their target price on shares of Marsh & McLennan Companies from $206.00 to $212.00 and gave the stock an "overweight" rating in a report on Monday, July 13th. Cantor Fitzgerald raised their price target on shares of Marsh & McLennan Companies from $210.00 to $218.00 and gave the company an "overweight" rating in a research report on Thursday, July 9th. Finally, Piper Sandler decreased their price objective on Marsh & McLennan Companies from $190.00 to $182.00 and set a "neutral" rating for the company in a report on Tuesday, May 26th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eleven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $201.94.

Marsh & McLennan Companies Price Performance

Shares of NYSE:MRSH opened at $187.75 on Friday. Marsh & McLennan Companies, Inc. has a 1 year low of $156.60 and a 1 year high of $213.80. The company has a market cap of $89.60 billion, a P/E ratio of 22.95, a PEG ratio of 2.71 and a beta of 0.59. The company has a fifty day simple moving average of $177.66. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.14 and a quick ratio of 1.14.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last released its earnings results on Tuesday, July 21st. The financial services provider reported $2.96 EPS for the quarter, topping analysts' consensus estimates of $2.89 by $0.07. The company had revenue of $7.28 billion for the quarter. Marsh & McLennan Companies had a return on equity of 32.67% and a net margin of 14.24%.The company's revenue for the quarter was up 6.2% on a year-over-year basis. Sell-side analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.43 earnings per share for the current year.

Marsh & McLennan Companies Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Thursday, July 23rd were paid a $0.99 dividend. The ex-dividend date was Thursday, July 23rd. This is a positive change from Marsh & McLennan Companies's previous quarterly dividend of $0.90. This represents a $3.96 dividend on an annualized basis and a yield of 2.1%. Marsh & McLennan Companies's dividend payout ratio is presently 48.41%.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source